
P.3.f.007 Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics
Vataire, A., Ferchichi, S., Desroziers, K., Cadi-Soussi, N., Murthy, V., Toumi, M.Volume:
23
Langue:
english
Journal:
European Neuropsychopharmacology
DOI:
10.1016/S0924-977X(13)70785-5
Date:
October, 2013
Fichier:
PDF, 59 KB
english, 2013